Company intelligence / Profile preview

Fortissimo Capital

Tel Aviv / Rosh Ha'ayin, Central District, Israel

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Fortissimo Capital is an Israeli private equity firm with $2.7 billion raised across six funds since 2004, investing in over 60 companies in technology, industrial, and healthcare sectors; it is industry-agnostic as an investor, not a developer of therapeutics or diagnostics[1][6][7].

Industry: Investors

Partnerships

Partners with portfolio companiesinternational financial institutions

Beyond the preview

Go deeper on Fortissimo Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fortissimo Capital.

Explore the full profile